Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.

Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, Fox NC, Sanchez-Valle R, Grau-Rivera O, Gelpi E, Seelaar H, Papma JM, van Swieten JC, Hodges JR, Leyton CE, Piguet O, Rogalsky EJ, Mesulam MM, Koric L, Nora K, Pariente J, Dickerson B, Mackenzie IR, Hsiung GR, Belliard S, Irwin DJ, Wolk DA, Grossman M, Jones M, Harris J, Mann D, Snowden JS, Chrem-Mendez P, Calandri IL, Amengual AA, Miguet-Alfonsi C, Magnin E, Magnani G, Santangelo R, Deramecourt V, Pasquier F, Mattsson N, Nilsson C, Hansson O, Keith J, Masellis M, Black SE, Matías-Guiu JA, Cabrera-Martin MN, Paquet C, Dumuirger J, Teichmann M, Sarazin M, Bottlaender M, Dubois B, Rowe CC, Villemagne VL, Vandenberghe R, Granadillo E, Teng E, Mendez M, Meyer PT, Frings L, Lleó A, Blesa R, Fortea J, Seo SW, Diehl-Schmid J, Grimmer T, Frederiksen KS, Sánchez-Juan P, Chételat G, Jansen W, Bouchard RW, Robert L Jr, Visser PJ, Ossenkoppele R.

Ann Neurol. 2018 Sep 26. doi: 10.1002/ana.25333. [Epub ahead of print]

PMID:
30255971
2.

Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study.

Jiskoot LC, Bocchetta M, Nicholas JM, Cash DM, Thomas D, Modat M, Ourselin S, Rombouts SARB, Dopper EGP, Meeter LH, Panman JL, van Minkelen R, van der Ende EL, Donker Kaat L, Pijnenburg YAL, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe J, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S; Genetic Frontotemporal dementia Initiative (GENFI), Papma JM, van Swieten JC, Rohrer JD.

Ann Clin Transl Neurol. 2018 Jul 11;5(9):1025-1036. doi: 10.1002/acn3.601. eCollection 2018 Sep.

3.

Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and women.

Sapkota S, Ramirez J, Stuss DT, Masellis M, Black SE.

Alzheimers Res Ther. 2018 Sep 5;10(1):89. doi: 10.1186/s13195-018-0419-2.

4.

Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts.

Lim ASP, Gaiteri C, Yu L, Sohail S, Swardfager W, Tasaki S, Schneider JA, Paquet C, Stuss DT, Masellis M, Black SE, Hugon J, Buchman AS, Barnes LL, Bennett DA, De Jager PL.

PLoS Med. 2018 Sep 4;15(9):e1002647. doi: 10.1371/journal.pmed.1002647. eCollection 2018 Sep.

5.

Brain tissue pulsatility is related to clinical features of Parkinson's disease.

Shirzadi Z, Robertson AD, Metcalfe AW, Duff-Canning S, Marras C, Lang AE, Masellis M, MacIntosh BJ.

Neuroimage Clin. 2018 Jul 23;20:222-227. doi: 10.1016/j.nicl.2018.07.017. eCollection 2018.

6.

Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound.

Lipsman N, Meng Y, Bethune AJ, Huang Y, Lam B, Masellis M, Herrmann N, Heyn C, Aubert I, Boutet A, Smith GS, Hynynen K, Black SE.

Nat Commun. 2018 Jul 25;9(1):2336. doi: 10.1038/s41467-018-04529-6.

7.

Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.

Sellami L, Bocchetta M, Masellis M, Cash DM, Dick KM, van Swieten J, Borroni B, Galimberti D, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni G, Finger E, de Mendonça A, Sorbi S, Warren JD, Rohrer JD, Laforce R; Genetic FTD Initiative, GENFI .

J Alzheimers Dis. 2018;65(1):147-163. doi: 10.3233/JAD-180053.

8.

Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis.

Mihaescu AS, Masellis M, Graff-Guerrero A, Kim J, Criaud M, Cho SS, Ghadery C, Valli M, Strafella AP.

Brain Imaging Behav. 2018 Jul 3. doi: 10.1007/s11682-018-9922-0. [Epub ahead of print]

PMID:
29971686
9.

Computer-Based Driving in Dementia Decision Tool With Mail Support: Cluster Randomized Controlled Trial.

Rapoport MJ, Zucchero Sarracini C, Kiss A, Lee L, Byszewski A, Seitz DP, Vrkljan B, Molnar F, Herrmann N, Tang-Wai DF, Frank C, Henry B, Pimlott N, Masellis M, Naglie G.

J Med Internet Res. 2018 May 25;20(5):e194. doi: 10.2196/jmir.9126.

10.

Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales.

Fumagalli GG, Basilico P, Arighi A, Bocchetta M, Dick KM, Cash DM, Harding S, Mercurio M, Fenoglio C, Pietroboni AM, Ghezzi L, van Swieten J, Borroni B, de Mendonça A, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, Sorbi S, Scarpini E, Rohrer JD, Galimberti D; Genetic FTD Initiative (GENFI).

Alzheimers Res Ther. 2018 May 24;10(1):46. doi: 10.1186/s13195-018-0376-9.

11.

APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.

Saeed U, Mirza SS, MacIntosh BJ, Herrmann N, Keith J, Ramirez J, Nestor SM, Yu Q, Knight J, Swardfager W, Potkin SG, Rogaeva E, St George-Hyslop P, Black SE, Masellis M.

Alzheimers Dement. 2018 Sep;14(9):1137-1147. doi: 10.1016/j.jalz.2018.04.005. Epub 2018 May 18.

PMID:
29782824
12.

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, Jacquette A, Colin O, Drapier S, Borg M, Fiksinski AM, Vergaelen E, Swillen A, Vogels A, Plate A, Perandones C, Gasser T, Clerinx K, Bourdain F, Mills K, Williams NM, Wood NW, Booij J, Lang AE, Bassett AS; International Research Group on 22q11.2DS-associated Parkinson's Disease.

Neurology. 2018 Jun 5;90(23):e2059-e2067. doi: 10.1212/WNL.0000000000005660. Epub 2018 May 11.

13.

Heritability estimates of cortical anatomy: The influence and reliability of different estimation strategies.

Patel S, Patel R, Park MTM, Masellis M, Knight J, Chakravarty MM.

Neuroimage. 2018 Sep;178:78-91. doi: 10.1016/j.neuroimage.2018.05.014. Epub 2018 May 6.

PMID:
29742386
14.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

PMID:
29724592
15.

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease.

Dilliott AA, Farhan SMK, Ghani M, Sato C, Liang E, Zhang M, McIntyre AD, Cao H, Racacho L, Robinson JF, Strong MJ, Masellis M, Bulman DE, Rogaeva E, Lang A, Tartaglia C, Finger E, Zinman L, Turnbull J, Freedman M, Swartz R, Black SE, Hegele RA.

J Vis Exp. 2018 Apr 4;(134). doi: 10.3791/57266.

16.

Association between maternal childhood maltreatment and mother-infant attachment disorganization: Moderation by maternal oxytocin receptor gene and cortisol secretion.

Ludmer JA, Gonzalez A, Kennedy J, Masellis M, Meinz P, Atkinson L.

Horm Behav. 2018 Jun;102:23-33. doi: 10.1016/j.yhbeh.2018.04.006. Epub 2018 Apr 24.

PMID:
29673618
17.

Age representation in antiepileptic drug trials: A systematic review and meta-analysis.

Desmarais P, Miville C, Milán-Tomás Á, Nguyen QD, Ojeda-López C, Masellis M, Black SE, Andrade DM, Herrmann N.

Epilepsy Res. 2018 May;142:9-15. doi: 10.1016/j.eplepsyres.2018.03.005. Epub 2018 Mar 6.

PMID:
29544171
18.

Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.

Schneider R, McKeever P, Kim T, Graff C, van Swieten JC, Karydas A, Boxer A, Rosen H, Miller BL, Laforce R Jr, Galimberti D, Masellis M, Borroni B, Zhang Z, Zinman L, Rohrer JD, Tartaglia MC, Robertson J; Genetic FTD Initiative (GENFI).

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):851-858. doi: 10.1136/jnnp-2017-317492. Epub 2018 Feb 6.

19.

The effect of white matter hyperintensities on verbal memory: Mediation by temporal lobe atrophy.

Swardfager W, Cogo-Moreira H, Masellis M, Ramirez J, Herrmann N, Edwards JD, Saleem M, Chan P, Yu D, Nestor SM, Scott CJM, Holmes MF, Sahlas DJ, Kiss A, Oh PI, Strother SC, Gao F, Stefanovic B, Keith J, Symons S, Swartz RH, Lanctôt KL, Stuss DT, Black SE.

Neurology. 2018 Feb 20;90(8):e673-e682. doi: 10.1212/WNL.0000000000004983. Epub 2018 Jan 26.

PMID:
29374101
20.

Comment: Unraveling DNA sequence to identify cerebral indicators of dementia risk.

Masellis M, Knight J.

Neurology. 2018 Jan 16;90(3):109. doi: 10.1212/WNL.0000000000004838. Epub 2017 Dec 27. No abstract available.

PMID:
29282334
21.

Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.

Cash DM, Bocchetta M, Thomas DL, Dick KM, van Swieten JC, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Rossor MN, Ourselin S, Rohrer JD; Genetic FTD Initiative, GENFI.

Neurobiol Aging. 2018 Feb;62:191-196. doi: 10.1016/j.neurobiolaging.2017.10.008. Epub 2017 Oct 19.

22.

Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.

Galimberti D, Fumagalli GG, Fenoglio C, Cioffi SMG, Arighi A, Serpente M, Borroni B, Padovani A, Tagliavini F, Masellis M, Tartaglia MC, van Swieten J, Meeter L, Graff C, de Mendonça A, Bocchetta M, Rohrer JD, Scarpini E; Genetic FTD Initiative (GENFI).

Neurobiol Aging. 2018 Feb;62:245.e9-245.e12. doi: 10.1016/j.neurobiolaging.2017.10.016. Epub 2017 Nov 13.

23.

Disinhibition in Alzheimer's Disease is Associated with Reduced Right Frontal Pole Cortical Thickness.

Finger E, Zhang J, Dickerson B, Bureau Y, Masellis M; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;60(3):1161-1170. doi: 10.3233/JAD-170348.

PMID:
28984590
24.

Unraveling PINK1 regulation: Ubiquitination of its mature form and insights for Parkinson's disease.

Saeed U, Masellis M.

Mov Disord. 2017 Nov;32(11):1546. doi: 10.1002/mds.27171. Epub 2017 Oct 4. No abstract available.

PMID:
28976028
25.

Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis.

Curtis AF, Masellis M, Hsiung GR, Moineddin R, Zhang K, Au B, Millett G, Mackenzie I, Rogaeva E, Tierney MC.

Neurology. 2017 Oct 10;89(15):1633-1642. doi: 10.1212/WNL.0000000000004494. Epub 2017 Sep 15. Review.

26.

Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration.

Espay AJ, Da Prat GA, Dwivedi AK, Rodriguez-Porcel F, Vaughan JE, Rosso M, Devoto JL, Duker AP, Masellis M, Smith CD, Mandybur GT, Merola A, Lang AE.

Ann Neurol. 2017 Oct;82(4):503-513. doi: 10.1002/ana.25046. Epub 2017 Oct 4. Review.

PMID:
28892572
27.

Maternal DRD2, SLC6A3, and OXTR genotypes as potential moderators of the relation between maternal history of care and maternal cortisol secretion in the context of mother-infant separation.

Ludmer JA, Jamieson B, Gonzalez A, Levitan R, Kennedy J, Villani V, Masellis M, Basile VS, Atkinson L.

Biol Psychol. 2017 Oct;129:154-164. doi: 10.1016/j.biopsycho.2017.09.004. Epub 2017 Sep 7.

PMID:
28890000
28.

Dopamine receptor D2 (DRD2), dopamine transporter solute carrier family C6, member 4 (SLC6A3), and catechol-O-methyltransferase (COMT) genes as moderators of the relation between maternal history of maltreatment and infant emotion regulation.

Villani V, Ludmer J, Gonzalez A, Levitan R, Kennedy J, Masellis M, Basile VS, Wekerle C, Atkinson L.

Dev Psychopathol. 2018 May;30(2):581-592. doi: 10.1017/S0954579417001122. Epub 2017 Aug 14.

PMID:
28803562
29.

Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease.

Swardfager W, Yu D, Scola G, Cogo-Moreira H, Chan P, Zou Y, Herrmann N, Lanctôt KL, Ramirez J, Gao F, Masellis M, Swartz RH, Sahlas DJ, Chan PC, Ojeda-Lopez C, Milan-Tomas A, Pettersen JA, Andreazza AC, Black SE.

Neurobiol Aging. 2017 Nov;59:91-97. doi: 10.1016/j.neurobiolaging.2017.06.029. Epub 2017 Jul 11.

PMID:
28756941
30.

Social inappropriateness in neurodegenerative disorders.

Desmarais P, Lanctôt KL, Masellis M, Black SE, Herrmann N.

Int Psychogeriatr. 2018 Feb;30(2):197-207. doi: 10.1017/S1041610217001260. Epub 2017 Jul 10.

PMID:
28689508
31.

Enhancement of automated blood flow estimates (ENABLE) from arterial spin-labeled MRI.

Shirzadi Z, Stefanovic B, Chappell MA, Ramirez J, Schwindt G, Masellis M, Black SE, MacIntosh BJ.

J Magn Reson Imaging. 2018 Mar;47(3):647-655. doi: 10.1002/jmri.25807. Epub 2017 Jul 6.

PMID:
28681479
32.

Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).

Montero-Odasso M, Pieruccini-Faria F, Bartha R, Black SE, Finger E, Freedman M, Greenberg B, Grimes DA, Hegele RA, Hudson C, Kleinstiver PW, Lang AE, Masellis M, McLaughlin PM, Munoz DP, Strother S, Swartz RH, Symons S, Tartaglia MC, Zinman L, Strong MJ; ONDRI Investigators, McIlroy W.

J Alzheimers Dis. 2017;59(2):707-721. doi: 10.3233/JAD-170149.

33.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

34.

Heritability of hippocampal subfield volumes using a twin and non-twin siblings design.

Patel S, Park MTM, Devenyi GA, Patel R, Masellis M, Knight J, Chakravarty MM.

Hum Brain Mapp. 2017 Sep;38(9):4337-4352. doi: 10.1002/hbm.23654. Epub 2017 May 31.

PMID:
28561418
35.

White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort.

Sudre CH, Bocchetta M, Cash D, Thomas DL, Woollacott I, Dick KM, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni G, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Ourselin S, Cardoso MJ, Rohrer JD; Genetic FTD Initiative, GENFI.

Neuroimage Clin. 2017 Apr 26;15:171-180. doi: 10.1016/j.nicl.2017.04.015. eCollection 2017.

36.

Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI).

Mutsaerts HJMM, Petr J, Thomas DL, De Vita E, Cash DM, van Osch MJP, Golay X, Groot PFC, Ourselin S, van Swieten J, Laforce R Jr, Tagliavini F, Borroni B, Galimberti D, Rowe JB, Graff C, Pizzini FB, Finger E, Sorbi S, Castelo Branco M, Rohrer JD, Masellis M, MacIntosh BJ; GENFI investigators.

J Magn Reson Imaging. 2018 Jan;47(1):131-140. doi: 10.1002/jmri.25751. Epub 2017 May 8.

PMID:
28480617
37.

Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.

Premi E, Grassi M, van Swieten J, Galimberti D, Graff C, Masellis M, Tartaglia C, Tagliavini F, Rowe JB, Laforce R Jr, Finger E, Frisoni GB, de Mendonça A, Sorbi S, Gazzina S, Cosseddu M, Archetti S, Gasparotti R, Manes M, Alberici A, Cardoso MJ, Bocchetta M, Cash DM, Ourselin S, Padovani A, Rohrer JD, Borroni B; Genetic FTD Initiative (GENFI).

Brain. 2017 Jun 1;140(6):1784-1791. doi: 10.1093/brain/awx103.

38.

Collagenosis of the Deep Medullary Veins: An Underrecognized Pathologic Correlate of White Matter Hyperintensities and Periventricular Infarction?

Keith J, Gao FQ, Noor R, Kiss A, Balasubramaniam G, Au K, Rogaeva E, Masellis M, Black SE.

J Neuropathol Exp Neurol. 2017 Apr 1;76(4):299-312. doi: 10.1093/jnen/nlx009.

PMID:
28431180
39.

Development of cognitive screening test for the severely hearing impaired: Hearing-impaired MoCA.

Lin VY, Chung J, Callahan BL, Smith L, Gritters N, Chen JM, Black SE, Masellis M.

Laryngoscope. 2017 May;127 Suppl 1:S4-S11. doi: 10.1002/lary.26590.

PMID:
28409842
40.

The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.

Lehericy S, Vaillancourt DE, Seppi K, Monchi O, Rektorova I, Antonini A, McKeown MJ, Masellis M, Berg D, Rowe JB, Lewis SJG, Williams-Gray CH, Tessitore A, Siebner HR; International Parkinson and Movement Disorder Society (IPMDS)-Neuroimaging Study Group.

Mov Disord. 2017 Apr;32(4):510-525. doi: 10.1002/mds.26968. Epub 2017 Mar 28. Review.

PMID:
28370449
41.

Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.

Butcher NJ, Marras C, Pondal M, Rusjan P, Boot E, Christopher L, Repetto GM, Fritsch R, Chow EWC, Masellis M, Strafella AP, Lang AE, Bassett AS.

Brain. 2017 May 1;140(5):1371-1383. doi: 10.1093/brain/awx053.

PMID:
28369257
42.

Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.

Saeed U, Compagnone J, Aviv RI, Strafella AP, Black SE, Lang AE, Masellis M.

Transl Neurodegener. 2017 Mar 28;6:8. doi: 10.1186/s40035-017-0076-6. eCollection 2017. Review.

43.

Development of a decision-making tool for reporting drivers with mild dementia and mild cognitive impairment to transportation administrators.

Cameron DH, Zucchero Sarracini C, Rozmovits L, Naglie G, Herrmann N, Molnar F, Jordan J, Byszewski A, Tang-Wai D, Dow J, Frank C, Henry B, Pimlott N, Seitz D, Vrkljan B, Taylor R, Masellis M, Rapoport MJ.

Int Psychogeriatr. 2017 Sep;29(9):1551-1563. doi: 10.1017/S1041610217000242. Epub 2017 Mar 22.

PMID:
28325164
44.

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JÁ, Cilia R, Ballanger B, Niethammer M, Stoessl JA; IPMDS-Neuroimaging Study Group.

Mov Disord. 2017 Feb;32(2):181-192. doi: 10.1002/mds.26907. Epub 2017 Feb 2. Review.

PMID:
28150432
45.

Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.

Nestor SM, Mišić B, Ramirez J, Zhao J, Graham SJ, Verhoeff NPLG, Stuss DT, Masellis M, Black SE.

Alzheimers Dement. 2017 Jul;13(7):749-760. doi: 10.1016/j.jalz.2016.12.007. Epub 2017 Jan 27.

PMID:
28137552
46.

The spatial coefficient of variation in arterial spin labeling cerebral blood flow images.

Mutsaerts HJ, Petr J, Václavů L, van Dalen JW, Robertson AD, Caan MW, Masellis M, Nederveen AJ, Richard E, MacIntosh BJ.

J Cereb Blood Flow Metab. 2017 Sep;37(9):3184-3192. doi: 10.1177/0271678X16683690. Epub 2017 Jan 6.

47.

The Ontario Neurodegenerative Disease Research Initiative (ONDRI).

Farhan SM, Bartha R, Black SE, Corbett D, Finger E, Freedman M, Greenberg B, Grimes DA, Hegele RA, Hudson C, Kleinstiver PW, Lang AE, Masellis M, McIlroy WE, McLaughlin PM, Montero-Odasso M, Munoz DG, Munoz DP, Strother S, Swartz RH, Symons S, Tartaglia MC, Zinman L; ONDRI Investigators, Strong MJ.

Can J Neurol Sci. 2017 Mar;44(2):196-202. doi: 10.1017/cjn.2016.415. Epub 2016 Dec 22.

PMID:
28003035
48.

Lack of Frank Agrammatism in the Nonfluent Agrammatic Variant of Primary Progressive Aphasia.

Graham NL, Leonard C, Tang-Wai DF, Black S, Chow TW, Scott CJ, McNeely AA, Masellis M, Rochon E.

Dement Geriatr Cogn Dis Extra. 2016 Sep 23;6(3):407-423. eCollection 2016 Sep-Dec.

49.

Qualitative analysis of emergency department reports applied to a pilot project for the prevention of pediatric burns.

Longo E, Masellis M, Fondi G, Cedri C, Debbia C, Pitidis A.

Ann Burns Fire Disasters. 2015 Dec 31;28(4):247-252.

50.

Characterizing familial corticobasal syndrome due to Alzheimer's disease pathology and PSEN1 mutations.

Lam B, Khan A, Keith J, Rogaeva E, Bilbao J, St George-Hyslop P, Ghani M, Freedman M, Stuss DT, Chow T, Black SE, Masellis M.

Alzheimers Dement. 2017 May;13(5):520-530. doi: 10.1016/j.jalz.2016.08.014. Epub 2016 Oct 12.

PMID:
27743520

Supplemental Content

Loading ...
Support Center